- In May 2022, CONMED Corporation entered into a definitive agreement to acquire In2Bones Global, Inc., a privately-held company. In2Bones specializes in the development, manufacturing, and distribution of medical devices aimed at treating disorders and injuries of both the upper (hand, wrist, elbow) and lower (foot and ankle) extremities. Their extensive product portfolio includes implants, fracture systems, biologics, and associated hardware
- In February 2022, DePuy Synthes, a subsidiary of Johnson & Johnson Medical Devices, acquired CrossRoads Extremity Systems, which provides a range of procedure-specific, sterile-packed implants and instruments designed for the lower extremities
